Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JA84 | ISIN: US2265521078 | Ticker-Symbol:
NASDAQ
17.01.25
20:33 Uhr
5,325 US-Dollar
+0,025
+0,47 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
CREXENDO INC Chart 1 Jahr
5-Tage-Chart
CREXENDO INC 5-Tage-Chart
ACCESS Newswire
220 Leser
Artikel bewerten:
(1)

Crexendo, Inc.: Crexendo International is Honored as Finalist for Comms Council UK 2024 Awards

Finanznachrichten News

PHOENIX, AZ / ACCESSWIRE / July 30, 2024 / Crexendo®, Inc. (NASDAQ:CXDO), an award-winning premier provider of cloud communication platforms and services, video collaboration and managed IT services designed to provide enterprise-class cloud solutions to any size business, today announced that its NetSapiens Platform has been named a finalist in the Best Industry Enabler category at the prestigious 2024 Comms Council UK Awards. This recognition highlights Crexendo's commitment to driving innovation and excellence in the telecommunications industry on a global stage.

The Comms Council UK Awards celebrate the very best in the communications industry, recognizing companies who have demonstrated outstanding achievements and contributions. Being nominated for this award underscores the global impact and industry leadership of Crexendo's NetSapiens Platform.

"We are honored to be named a finalist by the Comms Council UK. This nomination is a testament to our relentless pursuit of excellence and innovation in the telecommunications sector," said Scott Goodwin, Senior Vice President of International Markets at Crexendo. "Our NetSapiens Platform is engineered to revolutionize service delivery for providers worldwide. This esteemed international recognition not only validates our relentless pursuit of innovation but also underscores our commitment to transforming global communications."

"Being recognized by the Comms Council UK is a significant milestone for Crexendo on the international stage. We are particularly gratified as an American Company with this recognition. Our NetSapiens Platform has revolutionized the way communication services are delivered," said Jeff Korn Crexendo CEO and Chairman. "This nomination highlights our substantial international growth which I only expect to accelerate. We are committed to continuing our journey of innovation and excellence, providing world-class solutions to our customers globally."

Crexendo's NetSapiens Platform offers a comprehensive suite of unified communications solutions, enabling service providers to deliver reliable, scalable, and feature-rich services to their customers. With a focus on flexibility, customization, and seamless integration, the NetSapiens Platform is designed to meet the diverse needs of service providers in various markets.

The winners of the 2024 Comms Council UK Awards will be announced at a gala ceremony in London later this year. Crexendo looks forward to participating in the event and celebrating with other industry leaders and innovators.

For more information about Crexendo and its award-winning solutions, please visit www.crexendo.com.

About Crexendo

Crexendo, Inc. is an award-winning premier provider of cloud communication platforms and services, video collaboration and managed IT services designed to provide enterprise-class cloud solutions to any size business. Our solutions currently support over four and a half million end users globally.

Safe Harbor Statement

This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. The words "believe," "expect," "anticipate," "estimate," "will" and other similar statements of expectation identify forward-looking statements. Specific forward-looking statements in this press release include information about Crexendo (i) being honored to be named a finalist by the Comms Council UK; (ii) nomination being a testament to its relentless pursuit of excellence and innovation in the telecommunications sector; (iii) NetSapiens Platform being engineered to revolutionize service delivery for providers worldwide; (iv) believing this recognition validates its relentless pursuit of innovation and underscores its commitment to transforming global communications; (v) believing the recognition is a significant milestone on the international stage; (vi) being particularly gratified as an American Company with this recognition; (vii) believing the NetSapiens Platform has revolutionized the way communication services are delivered; (viii) believing this nomination highlights the substantial international growth which is only expected to accelerate and (ix) being committed to continuing the journey of innovation and excellence, providing world-class solutions to our customers globally.".

For a more detailed discussion of risk factors that may affect Crexendo's operations and results, please refer to the company's Form 10-K for the year ended December 31, 2023, and quarterly Form 10-Qs as filed with the SEC. These forward-looking statements speak only as of the date on which such statements are made, and the company undertakes no obligation to update such forward-looking statements, except as required by law.

Company Contact:

Crexendo, Inc.
Doug Gaylor
President and Chief Operating Officer
602-732-7990
dgaylor@crexendo.com

SOURCE: Crexendo, Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.